What is Repligen's revenue?

Repligen (RGEN) generated $734.6M in revenue over the trailing twelve months, up 16.3% year over year.

Is Repligen profitable?

Repligen reported $51.4M in net income over the trailing twelve months, a 17.1% net margin.

What are Repligen's profit margins?

Gross margin is 49.5% and operating margin is 1.5%, with a 17.1% net margin.

What is Repligen's earnings per share?

Repligen's diluted EPS over the trailing twelve months is $0.77.

Where does Repligen's income statement data come from?

Every line is extracted from Repligen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Repligen RGEN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$194.26M—	——	$188.81M+3.5%	$182.37M+7.8%	$169.17M—
Total cost of revenue	$85.97M—	——	$88.29M-3.2%	$91.22M+17.3%	$77.8M—
Research and development	$14.46M—	——	$14.18M+1.6%	$13.96M+15.2%	$12.11M—
Selling, general and administrative	$76.54M—	——	$73.66M+3.4%	$71.23M+0.7%	$70.71M—
Compensation and benefits	$8.32M—	——	$8.97M+7.1%	$8.38M+15.2%	$7.27M—
Depreciation and amortization	$19.76M-0.9%	$19.95M-0.3%	$20.01M-0.4%	$20.08M+7.4%	$18.7M+1.8%
Restructuring charges	$1.5M—	——	——	$2.16M+9.6%	$1.97M—
Total costs & expenses	$178.32M—	——	$171.98M+2.1%	$168.47M+3.6%	$162.59M—
Operating income	$15.94M—	——	$16.83M+21.1%	$13.9M+111%	$6.58M—
Operating margin	8.2%—	——	8.9%+1.3pp	7.6%+3.7pp	3.9%—
Interest expense	$5.58M—	——	$5.41M+1.1%	$5.35M+2.0%	$5.25M—
Interest income	$6.34M—	——	$6.92M+5.1%	$6.59M-10.0%	$7.31M—
Other income (expense), net	-$14.17M—	——	$287K-93.4%	$4.32M+216%	$1.37M—
Gain (loss) on disposal of assets	-$13.76M—	——	——	——	$0—
Net investment gains (losses)	$0—	——	——	——	——
Income before income taxes	$1.77M—	——	$17.11M-6.1%	$18.22M+129%	$7.94M—
Income tax expense	-$6.56M—	——	$2.2M-34.3%	$3.35M+58.5%	$2.11M—
Net income	$8.33M-37.3%	$13.29M-10.9%	$14.91M+0.3%	$14.87M+155%	$5.83M+117%
Net margin	4.3%—	——	7.9%-0.3pp	8.2%+4.7pp	3.4%—
Diluted earnings per share	$0.15—	——	$0.260.0%	$0.26+160%	$0.10—
Basic earnings per share	$0.15—	——	$0.27+3.8%	$0.26+160%	$0.10—
Weighted-average shares, diluted	56.7M—	——	56.5M0.0%	56.5M-0.1%	56.6M—
Weighted-average shares, basic	56.4M—	——	56.3M+0.1%	56.2M+0.2%	56.1M—
Acquisition Date Fair Value Of Contingent Consideration Earnouts	——	$0—	$0—	$0—	$0-100%
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	$5.54M—	——	$824K+21.9%	$676K-89.6%	$6.49M—
Share-based compensation expense related to employee stock plans	$8.32M—	——	$8.97M+7.1%	$8.38M+15.2%	$7.27M—
Amortization Of Financing Costs And Discounts	$4.37M+2.0%	$4.29M—	——	——	$4.04M+2.0%
Amortization of capitalized software and acquired intangible assets	$9.8M—	——	$9.9M-3.9%	$10.3M+13.2%	$9.1M—
Stock options excluded as their inclusion would be anti-dilutive (in shares)	520K—	——	652.9K-0.2%	654K+59.9%	409K—
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1	-$146K—	——	-$4.15M+47.8%	-$7.94M—	$0—
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	$18.62M—	——	——	——	-$60.13M—
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$3.45M—	——	$12.52M-79.5%	$60.99M+480%	$10.52M—
Concentration Risk Percentage1	100%—	——	100%0.0%	100%0.0%	100%—
Revenue recognized that was included in deferred income at the beginning of the period	$6.2M—	——	——	——	$5.3M—
Additions (reductions) for expected credit losses on securities where credit losses were previously recognized	$0—	——	——	——	——
Total net securities (losses)	$0—	——	——	——	——
Deferred taxes	-$7.7M—	——	-$3.22M-136%	-$1.37M-13.4%	-$1.2M+90.5%
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash	-$145K-222%	$119K—	$0-100%	$987K-75.4%	$4.01M+262%
Effective tax rates	-$3.7—	——	$0.13-29.9%	$0.18-30.8%	$0.27—
Gain (Loss), Foreign Currency Transaction, before Tax	-$38K-107%	$571K+201%	$190K-95.3%	$4.05M-50.7%	$8.21M—
Gain on sale of business and assets	-$13.76M—	——	——	——	$0—
Foreign Currency Translation and Other Adjustments	$6.82M—	——	——	-$31.84M-2,379%	-$1.28M—
Goodwill, Written off Related to Sale of Business Unit	$713K—	——	——	——	——
Accounts payable	$5.92M—	——	——	-$1.58M+76.3%	-$6.69M-160%
Increase (Decrease) in Accounts Receivable	-$3.19M-132%	$9.86M—	——	$5.24M-47.2%	$9.92M+5.5%
Accrued liabilities	-$12.66M-679%	$2.18M-82.7%	$12.62M+363%	-$4.8M-366%	$1.81M+142%
Increase (Decrease) in Inventories	$12.07M+25.7%	$9.6M+112%	$4.52M—	——	$3.83M+110%
Short- and long-term operating lease liabilities	-$5.59M-61.7%	-$3.46M-51.0%	-$2.29M+53.9%	-$4.97M-2.7%	-$4.84M-98.0%
Increase (decrease) in other assets	-$26K—	——	$180K-47.8%	$345K-71.3%	$1.2M—
Increase (decrease) in all other liabilities	$1.27M+152%	-$2.45M-485%	$637K+391%	-$219K-146%	$475K-91.3%
Increase (Decrease) in Prepaid Expense and Other Assets	$1.98M-12.6%	$2.26M-57.5%	$5.32M—	——	$2.19M+153%
Add - Incremental shares associated with contingently issuable shares (in shares)	0—	——	——	——	56K—
Debt	$5.87M—	——	$5.7M—	——	$5.54M—
Net interest and investment income (loss)	$6.34M—	——	$6.92M+5.1%	$6.59M-10.0%	$7.31M—
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$5.54M—	$0+100%	-$239K+97.6%	-$10.13M-101%	-$5.03M—
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$3.99M+98.1%	-$208.74M-2,582%	-$7.78M+0.7%	-$7.84M+89.4%	-$74.11M-14.4%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$28.3M+10.1%	$25.7M-46.6%	$48.1M+68.1%	$28.61M+90.7%	$15.01M-61.7%
Number of reportable segments	1—	——	——	——	——
Operating lease right-of-use assets amortization expense	$4.78M+2.9%	$4.64M—	——	——	$4.48M+8.3%
Unrealized gains (losses) on available-for-sale securities	-$113K—	——	——	——	——
Foreign currency translation gains (losses)	-$11.67M—	——	-$2.39M-105%	$46.13M+883%	$4.69M—
Net unrealized gains (losses) on securities still held	-$113K—	——	——	——	$0—
Other Noncash Income (Expense)	$1.33M—	——	-$2.18M—	——	-$10.48M-221%
Other income, net (Note 6)	-$750K—	——	-$804K-123%	$3.5M+1,324%	-$286K—
Other Restructuring Costs	-$336K—	——	——	——	——
Payment for (Proceeds from) Other Investing Activity	$416K—	——	——	——	$0+100%
Payments for Repurchase of Common Stock	——	$0—	$0—	$0—	$0—
Payments for Restructuring	$399K—	——	——	——	——
Payments of Debt Issuance Costs	——	$0—	$0—	$0—	$0—
Payment, Tax Withholding, Share-Based Payment Arrangement	$5.54M+561%	$839K+1.8%	$824K+21.9%	$676K-89.6%	$6.49M+1,256%
Payments to Acquire Businesses, Net of Cash Acquired	$0-100%	$374K—	$0-100%	$234K-99.7%	$69.72M+27.3%
Payments to Acquire Marketable Securities	$64.63M—	——	——	——	$0—
Payments to Acquire Property, Plant, and Equipment	$4.71M-42.2%	$8.15M+73.4%	$4.7M-33.8%	$7.1M+99.3%	$3.56M-35.7%
Payments To Acquire Software	$237K—	——	$684K+35.7%	$504K-41.9%	$867K—
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale	$66M—	——	——	——	$0—
Dispositions of property, plant, and equipment	$0-100%	$196K—	——	——	$42K+103%
Cash received from option exercises	$0-100%	$1.03M+52.5%	$678K—	$0-100%	$1.46M-24.1%
Stock-based compensation	$8.32M+4.2%	$7.98M-11.0%	$8.97M+7.1%	$8.38M+15.2%	$7.27M+14.4%
Weighted-average grant date fair value of stock options (in dollars per share)	$65.80—	——	——	——	$80.40—
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value	$129.34—	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period	39.1K—	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Number	567K—	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period	0—	——	——	——	——
Forfeited or expired (in shares)	$0.00—	——	——	——	——
Options granted (in shares)	48.2K—	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value	$155.80—	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value	$165.09—	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period	116.8K—	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period	211.5K—	——	——	——	——
Intrinsic value of stock options exercised	$0—	——	$1.7M—	——	$2.6M—
Granted (in shares)	$125.03—	——	——	——	——
Exercised (in shares)	$0.00—	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	0—	——	——	——	——
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture	——	——	$677K—	——	$1.46M—
Add: dilutive effect of potential common shares (in shares)	$312K—	——	$267-3.3%	$276-99.9%	$435K—
EBIT	$15.94M—	——	$16.83M+21.1%	$13.9M+111%	$6.58M—
EBITDA	$35.7M—	——	$36.83M+8.4%	$33.98M+34.4%	$25.28M—
EBITDA	$35.7M—	——	$36.83M+8.4%	$33.98M+34.4%	$25.28M—
EBITDA margin	18.4%—	——	19.5%+0.9pp	18.6%+3.7pp	14.9%—
EBIT	$15.94M—	——	$16.83M+21.1%	$13.9M+111%	$6.58M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Repligen.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's revenue?: Repligen (RGEN) generated $734.6M in revenue over the trailing twelve months, up 16.3% year over year.
Is Repligen profitable?: Repligen reported $51.4M in net income over the trailing twelve months, a 17.1% net margin.
What are Repligen's profit margins?: Gross margin is 49.5% and operating margin is 1.5%, with a 17.1% net margin.
What is Repligen's earnings per share?: Repligen's diluted EPS over the trailing twelve months is $0.77.
Where does Repligen's income statement data come from?: Every line is extracted from Repligen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.